Serum levels of leptin, adiponectin, retinol binding protein 4 and leptin/adiponectin molar ratio as another possible marker of insulin resistance in obese

Bratislava Medical Journal

Volumn 111, Issue 4, 2010, Pages 212-215

  Tajtakova, M ^a   Petrasova, D ^a   Pidanicova, A ^a   Gallovicova, A ^a   Blanarova, C ^a   Petrovicova, J ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Adiponectin; Insulin resistance; L A; Leptin; Obesity; RBP4

Indexed keywords

ADIPONECTIN; LEPTIN; PLASMA RETINOL BINDING PROTEIN;

ARTICLE; BLOOD; FEMALE; HUMAN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY;

ADIPONECTIN; FEMALE; HUMANS; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED; OBESITY; RETINOL-BINDING PROTEINS, PLASMA;

EID: 77954482444     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Anderwald C, Roden M. Adipotoxicity and the insulin resistance syndrome. Pediatr Endocrinol Rev 2004; 1: 310-319.
2. Bays HE, Abate N, Chandalia M. Adiposopathy: sick faty causes high blood sugar, high blood pressure, and dislipidemia. Future Cardi ology 2005; 1:39-59.
3. Carvalho E, Kotani K, Peroni OD, Kahn BB. Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle. Am J Physiol Endocrinol Metab 2005; 289: E 551-E 561.
4. Eldor R, Raz I. Lipotoxicity versus adipotoxicity. The deleterious effects of adipose tissue on beta cells in the pathogenesis of type 2 dia betes. Diabetes Res Clin Pract 2006; 74 S: S3-S8.
5. Gil-Campos M, Canete RR, Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 2004; 23: 963-974.
6. Graham TE, Yang Q, Bluher M et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. New Engl J Med 2006; 354: 2552-2563.
7. Cho YM, Youn BS, Lee H et al. Plasma retinol-binding protein-4 concentrations are eleved in human subjects with impaired glucose to lerance and type 2 diabetes. Diabetes Care 2006; 29: 2457-2461.
8. Lee YH, Pratley RE. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep 2005; 5: 70-75.
9. Lee DC, Lee JW, Im JA. Association of serum retinol binding pro tein 4 and insulin resistance in apparently healthy adolescents. Metabo lism 2007; 56: 327-331.
10. Lihn AS, Pedersen SB, Richelsen B. Adiponectin: action, regula tion and association to insulin sensitivity. Obes Rev 2005; 6: 13-21.
11. Maahs DM, Ogden LG, Kinney G L et al. Low plasma adiponec tin levels predict progression of coronary artery clasification. Circula tion 2005; 111: 747-753.
12. Mather KJ, Funahashi T, Matsuzawa Y et al. Adiponectin,change in adiponectin, and progression to diabetes in the diabets prevention program. Diabetes 2008; 57: 980-986.
13. Matsuzawa Y. Adiponectin: Identificatitoin, physiology and clini cal relevance in matabolic and vascular disease. Atherosclerosis Supl 2005; 6: 7-14.
14. Norico Satoh, Mitsuhide Naruse, Takeshi Usui et al. Leptin-to-The endocrine function of adiponectin ratio as a potential atherogenic index in obese type 2 dia-betic patients. Diabetes Care 2004; 27: 2488-2490.
15. Oda N, Imamura S, Fujita T et al. The ratio of leptin to adiponec-tin can be used as an index of insulin resistance. Metab Clin Exper 2008, 57. 268 273.
16. Palomer X, Perez A, Blanco-Vaca F. Adiponectin: anew link. between obesity, insulin resistance and cardiovascular disease. Med Clin (Barc) 2005; 124: 388-395.
17. Perseghin G, Lattuada G, De Gobelli F et al. Serum retinol- bin-ding protein-4, leptin and adiponectin concentrations are related to ec- topic fat accumulation. J Clin Endocrinol Metab 2007; 92:4883-4888.
18. Redinger RN. The physiology of adiposity. J Ky Med Assoc 2008; Med 106: 53-62.
19. Ronti T, Lupattelli G, Mannarino E. adipose tissue: An uptade. Clin Endocrinol 2006; 64: 355-365.
20. soodini GR. Adiponectin and leptin in relation to msulm sensitivi-ty. Metab Syndr Relat Disord 2004; 2: 114-123.
21. Sonnenberg GE, Krakower GR, Kissebah AH. A novel path-way to the mamfestations of metabolic syndrome. Obes Res 2004; 12.
22. Takebayashi K, Suetsugu M, Wakabayashi S et al. Retmol bmdmg protem-4 levels and clinical features ol type 2 diabetes patients. J 17. 2712-2719.
23. Irujulo ME, scherer PE. Adiponectin - journey from an adipo-cyty secretory protein to biomarker ol the metabolic syndrome. J Intern 2005; 257: 167-175.